Studies show that the use of Zofran in the first trimester can be detrimental to early fetal development

The personal injury firm of Hupy and Abraham, S.C has announced that it is now accepting cases involving Zofran (ondansetron), an anti-nausea medication. Typically, Zofran is prescribed to chemotherapy and radiation patients, but it is commonly administered “off-label” to pregnant women to combat morning sickness. Research has revealed that Zofran is dangerous for fetuses in early development, and increases the risk of birth defects,congenial heart defects, and jaundice. The U.S. Food and Drug Administration has never approved Zofran for use against morning sickness.

In addition to the Zofran cases, Hupy and Abraham also accepts metal on metal hip implant cases, DePuy hip implant cases, Xarelto cases, Granuflo cases, Naturalyte cases, testosterone drug cases, power morcellator cases and pelvic mesh cases.

If you or a loved one has a baby that was born with a birth defect after taking Zofran, please contact Hupy and Abraham, S.C. at 800-800-5678.

Jill Erin Wellskopf
Connect with me
Director of Marketing, Hupy and Abraham